-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UFW38osDQpfjYBFthhDxUrT/ENWzkbhRVa0AL36auAqEvBLbJYo/TuAthTnRDCvf DjVLNhYSeliV6brA9Q/7RQ== 0001209191-04-026314.txt : 20040518 0001209191-04-026314.hdr.sgml : 20040518 20040518141618 ACCESSION NUMBER: 0001209191-04-026314 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040426 FILED AS OF DATE: 20040518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC CENTRAL INDEX KEY: 0001072379 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943306718 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 21720-23RD DRIVE SE, SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4256083000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hemphill Robert F Jr. CENTRAL INDEX KEY: 0001289628 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815674 BUSINESS ADDRESS: BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powers Linda F CENTRAL INDEX KEY: 0001289624 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815677 BUSINESS ADDRESS: BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robertson Bruce C CENTRAL INDEX KEY: 0001289625 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815675 BUSINESS ADDRESS: BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toucan Management, LLC CENTRAL INDEX KEY: 0001289626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815673 BUSINESS ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toucan General II, LLC CENTRAL INDEX KEY: 0001289627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815679 BUSINESS ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Toucan Capital Fund II, LP CENTRAL INDEX KEY: 0001289580 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-33393 FILM NUMBER: 04815678 BUSINESS ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 2404974060 MAIL ADDRESS: STREET 1: 7600 WISCONSIN AVENUE STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0202 3/A 2004-04-26 2004-05-06 0 0001072379 NORTHWEST BIOTHERAPEUTICS INC NWBT 0001289580 Toucan Capital Fund II, LP 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 0001289624 Powers Linda F 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 0001289625 Robertson Bruce C 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 0001289628 Hemphill Robert F Jr. 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 0001289626 Toucan Management, LLC 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 0001289627 Toucan General II, LLC 7600 WISCONSIN AVENUE 7TH FLOOR BETHESDA MD 20814 0 0 1 0 10% Convertible Secured Promissory Notes 2005-04-26 Common Stock 8316008.0000 I see footnote Warrant 0.0100 2011-04-26 Common Stock 36000000.0000 I see footnote Consists of three 10% Convertible Secured Promissory Notes (the "Notes"), each of which was issued to Toucan Capital Fund II, L.P. ("Toucan Capital") on April 26, 2004 (the "Issuance Date"). The first Note (which was issued for cash) has a principal amount of $500,000 with interest accruing from the Issuance Date. The second Note (which was issued in consideration of the cancellation of a $50,000 promissory note originally issued to Toucan Capital on February 2, 2004) has a principal amount of $50,000 with interest accruing from February 2, 2004. The third Note (which was issued in consideration of the cancellation of a $50,000 promissory note originally issued to Toucan Capital on March 1, 2004) has a principal amount of $50,000 with interest accruing from March 1, 2004. The aggregate principal amount of, and accrued interest on, the Notes are immediately convertible at the option of Toucan Capital. The Notes are convertible into any debt or equity security authorized for issuance by the Issuer (currently only Common Stock). Exclusive of shares issuable upon conversion of accrued interest on the Notes. As of April 26, 2004, an aggregate of $1,918 of interest was accrued on the Notes, which interest was convertible into an aggregate of 26,581 shares of Common Stock. The conversion price for a discretionary conversion of the Notes is the lowest of: (i) the lowest nominal or effective price per share paid by any investor at any time on or after April 26, 2003 (subject to certain exceptions); (ii) the lowest nominal or effective price at which any investor is entitled to acquire shares pursuant to any other security, instrument, or promise, undertaking, commitment, agreement or letter of intent of the Issuer outstanding on or after April 26, 2004 or granted, issued, extended or otherwise made available by the Issuer at any time on or after April 26, 2003 (subject to certain exceptions); and (iii) the lesser of $0.10 per share or a 35% discount to the average closing price per share of the Common Stock during any twenty consecutive trading days beginning with the twenty consecutive trading days immediately preceding April 26, 2004 (with the limitation that the conversion price under this clause (iii) will be no less than $0.04 per share). Consists of securities held by Toucan Capital. Toucan General II, LLC ("Toucan General") is the general partner of Toucan Capital. Toucan Management, LLC ("Toucan Management") provides managerial services on behalf of Toucan General pursuant to a management contract. Linda F. Powers and Robert F. Hemphill, Jr. are managing members of Toucan General and Toucan Management. Ms. Powers and Mr. Hemphill and Bruce C. Robertson, Ph.D. are members of the investment committee of Toucan Capital. Each of the reporting persons disclaims beneficial ownership of the shares reported hereon except to the extent of his, her or its respective pecuniary interests therein. This warrant (the "Warrant") is exercisable upon the earliest to occur of: (i) the date that the Issuer has raised at least $2 million through the issuance of any class or series of Equity Security, Debt Security (each as defined in the Recapitalization Agreement) and/or combinations thereof (including, without limitation, any conversion of any Notes (as defined in the Recapitalization Agreement) and/or other convertible or exercisable securities and/or instruments other than the Bridge Warrants (as defined in the Recapitalization Agreement)); (ii) the date that the Issuer breaches any provision of the Recapitalization Agreement or any Related Recapitalization Document (as defined in the Recapitalization Agreement); (iii) the date that the Issuer accepts an Unsolicited Proposal (as defined in the Recapitalization Agreement); or (iv) sixty one (61) days after recieving notice from Holder of its intention to exercise the warrant. The Warrant is exercisable for any debt or equity security authorized for issuance by the Issuer (currently only Common Stock). /s/ Darren DeStefano, attorney-in-fact 2004-05-18 -----END PRIVACY-ENHANCED MESSAGE-----